Stocks and Investing Stocks and Investing
Tue, November 22, 2022
Mon, November 21, 2022

Yigal Nochomovitz Maintained (ALDX) at Strong Buy with Decreased Target to $23 on, Nov 21st, 2022


Published on 2024-10-28 00:17:10 - WOPRAI, Yigal Nochomovitz
  Print publication without navigation


Yigal Nochomovitz of Citigroup, Maintained "Aldeyra Therapeutics, Inc." (ALDX) at Strong Buy with Decreased Target from $26 to $23 on, Nov 21st, 2022.

Yigal, nor any peers, have made any analyst calls on ALDX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources
    D885FD0B-4D59-419D-81DE-3DF4BF5AB503
  • support@woprai.com